193 related articles for article (PubMed ID: 28237576)
1. Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression.
Deng R; Wu H; Ran H; Kong X; Hu L; Wang X; Su Q
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1065-1074. PubMed ID: 28237576
[TBL] [Abstract][Full Text] [Related]
2. Glucose-derived AGEs enhance human gastric cancer metastasis through RAGE/ERK/Sp1/MMP2 cascade.
Deng R; Mo F; Chang B; Zhang Q; Ran H; Yang S; Zhu Z; Hu L; Su Q
Oncotarget; 2017 Nov; 8(61):104216-104226. PubMed ID: 29262634
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H; Zhong Y; Zhou S; Peng L
Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
5. ZNF281 Regulates Cell Proliferation, Migration and Invasion in Colorectal Cancer through Wnt/β-Catenin Signaling.
Qin CJ; Bu PL; Zhang Q; Chen JT; Li QY; Liu JT; Dong HC; Ren XQ
Cell Physiol Biochem; 2019; 52(6):1503-1516. PubMed ID: 31112017
[TBL] [Abstract][Full Text] [Related]
6. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
7. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
[TBL] [Abstract][Full Text] [Related]
9. Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro.
Ko SY; Ko HA; Shieh TM; Chang WC; Chen HI; Chang SS; Lin IH
PLoS One; 2014; 9(10):e110542. PubMed ID: 25330185
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane inhibits the migration and invasion of colorectal cancer cells through regulating ERK/MMP-9 pathway by up-regulating miR-203.
Fan L; Wu Y; Wang J; He J; Han X
Eur J Pharmacol; 2019 May; 850():43-52. PubMed ID: 30685432
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.
Zhang TT; Jiang YY; Shang L; Shi ZZ; Liang JW; Wang Z; Zhang Y; Hao JJ; Jia XM; Xu X; Cai Y; Zhan QM; Wang MR
Mol Carcinog; 2015 Oct; 54(10):1205-13. PubMed ID: 25044025
[TBL] [Abstract][Full Text] [Related]
12. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
[TBL] [Abstract][Full Text] [Related]
13. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
Wang SY; Gao K; Deng DL; Cai JJ; Xiao ZY; He LQ; Jiao HL; Ye YP; Yang RW; Li TT; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Jan; 7(3):2878-88. PubMed ID: 26701208
[TBL] [Abstract][Full Text] [Related]
14. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.
Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ
World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793
[TBL] [Abstract][Full Text] [Related]
15. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
Oncol Rep; 2016 Sep; 36(3):1411-8. PubMed ID: 27430345
[TBL] [Abstract][Full Text] [Related]
16. Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer.
Zhang S; Xiao J; Chai Y; Hong Z; Liu Z; Yuan R; Luo Z; Zhou X; Lucero-Prisno DE; Huang K
Dig Dis Sci; 2018 Feb; 63(2):395-402. PubMed ID: 29260353
[TBL] [Abstract][Full Text] [Related]
17. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
Med Hypotheses; 2005; 64(6):1208-10. PubMed ID: 15823719
[TBL] [Abstract][Full Text] [Related]
18. The anti-metastatic effect of baicalein on colorectal cancer.
Chai Y; Xu J; Yan B
Oncol Rep; 2017 Apr; 37(4):2317-2323. PubMed ID: 28259937
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
[TBL] [Abstract][Full Text] [Related]
20. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
